FDA Clears Control-IQ+ for Type 2 Diabetes
In a significant stride for diabetes management, the U.S. Food and Drug Administration (FDA) has granted clearance to Tandem Diabetes Care’s Control-IQ+ technology for adults with type 2 diabetes. This approval marks a pivotal moment, […]
